Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Horizon's Tepezza Broke The Mold For 2020 Launches, But Still Got Snared By COVID-19

An Interview With CEO Tim Walbert

Mar 26 2021

• By Jessica Merrill

rocket, missile, spaceship — Tepezza has powered Horizon's growth strategy • Source: Shutterstock

Related Content

J.P. Morgan Extras: Pandemic Impact on Launch, Production, Development And More

Jan 18 2021

With $3bn Viela Acquisition, Horizon Builds A Pipeline

Feb 01 2021

Pandemic Perspectives: COVID-19 Upended Drug Launches In Ways That Will Stick

Mar 24 2021

Related Companies

Horizon Therapeutics plc

Moderna, Inc.

Viela Bio, Inc.

Takeda Pharmaceutical Co. Ltd.

Additional Topics

Launches Rare Diseases Business Strategies Advertising, Marketing & Sales Companies Commercial BioPharmaceutical

More from New Products

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window